Clinical Trial Update: Safety and Immunogenicity Study of the Recombinant Human Bovine Reassortant Rotavirus Vaccine in Healthy Indian Infants [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study of a recombinant human-bovine reassortant rotavirus vaccine in healthy Indian infants was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infections

Drugs mentioned

• Recombinant Human Bovine Reassortant Rotavirus Vaccine (Rotavirus vaccine, live, attenuated, reassortant)

Snippet

Sponsor: Shantha Biotechnics Limited | Conditions: Rotavirus Infections | Phase 1, Phase 2 | Status: WITHDRAWN